{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:20:04Z","timestamp":1773282004932,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/ico.0b013e3181605ff9","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T08:28:15Z","timestamp":1207816095000},"page":"446-453","source":"Crossref","is-referenced-by-count":34,"title":["Inhibition of Experimental Angiogenesis of Cornea by Various Doses of Doxycycline and Combination of Triamcinolone Acetonide With Low-molecular-weight Heparin and Doxycycline"],"prefix":"10.1097","volume":"27","author":[{"given":"Erdinc","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhamet","family":"Kivilcim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholam A","family":"Peyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Riazi","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Ahad","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: epidemiologic review.","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine.","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R3-11-20210204","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization.","volume":"37","author":"Reza Dana","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.","volume":"230","author":"Crum","year":"1985","journal-title":"Science"},{"key":"R6-11-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jop.1994.10.273","article-title":"Effect of low molecular weight heparan sulfate on angiogenesis in the rat cornea after chemical cauterization.","volume":"10","author":"Lepri","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/exer.1993.1177","article-title":"The effect of angiostatic steroids and B-Cyclodextrin tetradecasulfate on corneal neovascularization in rats.","volume":"57","author":"Proia","year":"1993","journal-title":"Exp Eye Res"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea.","volume":"4","author":"Mahoney","year":"1985","journal-title":"Curr Eye Res"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9394(79)90245-9","article-title":"Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas.","volume":"87","author":"Deutsch","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R10-11-20210204","first-page":"1588","article-title":"Effects of inhibitors of arachidonic acid metabolism on corneal neovascularization in rats.","volume":"30","author":"Haynes","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/02713688809031785","article-title":"Modulation of immunogenic keratitis in rabbits by topical administration of inhibitors of lipoxygenase and cyclooxygenase.","volume":"7","author":"Verbey","year":"1988","journal-title":"Curr Eye Res"},{"key":"R12-11-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/exer.1998.0512","article-title":"The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.","volume":"67","author":"Benelli","year":"1998","journal-title":"Exp Eye Res"},{"key":"R13-11-20210204","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-11-20210204","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jop.1996.12.425","article-title":"FK-506 delays corneal graft rejection in a model of corneal xenotransplantation.","volume":"12","author":"Benelli","year":"1996","journal-title":"J Ocul Pharmacol Ther"},{"key":"R15-11-20210204","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis.","volume":"91","author":"DAmato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-11-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1076\/ceyr.23.4.291.5453","article-title":"Effect of caffeic acid phenethyl ester on corneal neovascularization in rats.","volume":"23","author":"Totan","year":"2001","journal-title":"Curr Eye Res"},{"key":"R17-11-20210204","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines: effects on nitric oxide synthesis.","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-11-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"R19-11-20210204","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jbmr.5650081013","article-title":"Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase.","volume":"8","author":"Ramamurty","year":"1993","journal-title":"J Bone Miner Res"},{"key":"R20-11-20210204","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.ico.0000220768.11778.60","article-title":"Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.","volume":"25","author":"Riazi-Esfahani","year":"2006","journal-title":"Cornea"},{"key":"R21-11-20210204","first-page":"2898","article-title":"Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.","volume":"32","author":"Li","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-11-20210204","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(08)60471-8","article-title":"Heparin in inflammation: potential therapeutic applications beyond anticoagulation.","volume":"46","author":"Tyrrell","year":"1999","journal-title":"Adv Pharmacol"},{"key":"R24-11-20210204","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/mol.55.1.74","article-title":"In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor.","volume":"55","author":"Colin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"R25-11-20210204","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4899-2444-5_31","article-title":"Modulation of neovascularization and metastasis by species of heparin.","volume":"313","author":"Vlodavsky","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"R26-11-20210204","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.2467380","article-title":"Control of angiogenesis with synthetic heparin substitutes.","volume":"243","author":"Folkman","year":"1989","journal-title":"Science"},{"key":"R27-11-20210204","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.6192498","article-title":"Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.","volume":"221","author":"Folkman","year":"1983","journal-title":"Science"},{"key":"R28-11-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/exer.1998.0512","article-title":"The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.","volume":"67","author":"Benelli","year":"1998","journal-title":"Exp Eye Res"},{"key":"R29-11-20210204","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(24)01481-9","article-title":"The complex effects of heparins on cancer progression and metastasis in experimental studies.","volume":"53","author":"Smorenburg","year":"2001","journal-title":"Pharmacol Rev"},{"key":"R30-11-20210204","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/endo-119-4-1768","article-title":"A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.","volume":"119","author":"Ingber","year":"1986","journal-title":"Endocrinology"},{"key":"R31-11-20210204","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y99-055","article-title":"Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.","volume":"77","author":"Forget","year":"1999","journal-title":"Can J Physiol Pharmacol"},{"key":"R32-11-20210204","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj2680267","article-title":"Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).","volume":"268","author":"Williamson","year":"1990","journal-title":"Biochem J"},{"key":"R33-11-20210204","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/0006-291X(90)90822-5","article-title":"Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).","volume":"171","author":"Takigawa","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"R34-11-20210204","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jcp.1041600122","article-title":"Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.","volume":"160","author":"Johnson","year":"1994","journal-title":"J Cell Physiol"},{"key":"R35-11-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1994.tb24741.x","article-title":"Inhibition of tumor angiogenesis.","volume":"732","author":"Sipos","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"R36-11-20210204","first-page":"407","article-title":"Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells.","volume":"125","author":"Fife","year":"1995","journal-title":"J Lab Clin Med"},{"key":"R37-11-20210204","first-page":"1703","article-title":"Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.","volume":"41","author":"Sobrin","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R38-11-20210204","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells.","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv Dent Res"},{"key":"R39-11-20210204","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7","article-title":"Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.","volume":"42","author":"Smith","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R40-11-20210204","first-page":"975","article-title":"Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.","volume":"25","author":"Sorsa","year":"1998","journal-title":"J Rheumatol"},{"key":"R41-11-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.STR.0000129334.05181.b6","article-title":"Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model.","volume":"35","author":"Lee","year":"2004","journal-title":"Stroke"},{"key":"R42-11-20210204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(00)80931-9","article-title":"Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.","volume":"92","author":"Brooks","year":"1998","journal-title":"Cell"},{"key":"R43-11-20210204","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1073\/pnas.93.14.7069","article-title":"Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.","volume":"93","author":"Levi","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R44-11-20210204","doi-asserted-by":"crossref","first-page":"29568","DOI":"10.1074\/jbc.274.41.29568","article-title":"Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance.","volume":"274","author":"OReilly","year":"1999","journal-title":"J Biol Chem"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-200805000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:03:01Z","timestamp":1738166581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200805000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181605ff9","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}